ActiveNCT05622045

Does Personality Predict Patient Adherence, Health Behaviors, and Weight Loss Outcomes During the Latino Crossover Semaglutide Study (LCSS)? (Story-LCSS Project)

Sponsor: Loma Linda University

Trial Details

Condition	Obesity, Body Weight Changes
Intervention	Voice data
Status	Active
Participants	59
Est. Completion	29 May 2024
Last Updated	8 June 2026

Primary Outcome

Predicted patient weight change success; Clinician predictions; Predicated patient calorie intake; Predicated patient physical activity level

Eligibility Criteria

Inclusion Criteria

Inclusion Criteria: * Participation in the LCSS-Latino Crossover Semaglutide Study Exclusion Criteria: * Not a participant of the LCSS-Latino Crossover Semaglutide Study at the point of data collection

Trial Sites

Countries

United States

View Registry Entry

Related Analysis

Personality-Based Prediction Study Explores Weight Loss Success in Latino Patients on Semaglutide — Voice Analysis May Guide Clinical Decision-Making

New observational study uses voice analysis to predict weight loss success in Latino patients receiving semaglutide therapy. Research compares personality-based algorithmic predictions with clinician assessments to improve treatment personalisation.

Read full article →

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service